CINDY ILLESCAS: Open Payments
NPI 1720449358 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 5 payments from 3 companies in 2025. Trend: 2023 $1,497 · 2024 $667 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $370 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $122 |
Products named: UZEDY, REXULTI, Auvelity.
Industry payments across CA — which companies pay providers there.
